Efficacy of cascade-primed cell infusion as an adjuvant immunotherapy with concurrent chemotherapy for patients with non–small-cell lung cancer: A retrospective observational study with a 5-year follow-up-Reference-Cited by-同舟云学术

Efficacy of cascade-primed cell infusion as an adjuvant immunotherapy with concurrent chemotherapy for patients with non–small-cell lung cancer: A retrospective observational study with a 5-year follow-up

Published:2020-01 Issue:1 Volume:22 Page:35-43
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Li Hong,Zhang Zhen,Duan Xiaoran,Maimela Nomathamsanqa Resegofetse,Yang Shuangning,Zhao Xuan,Huang Jianmin,Zhang Yi

Funder

National Natural Science Foundation of China

Department of Science and Technology

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference37 articles.

1. Cancer Statistics, 2017;Siegel;CA: a cancer journal for clinicians,2017

2. Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC;Chang;Lung cancer (Amsterdam, Netherlands),2011

3. Safety and efficacy of gemcitabine or pemetrexed in combination with a platinum in patients with non-small-cell lung cancer and prior interstitial lung disease;Choi;Cancer chemotherapy and pharmacology,2014

4. Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens;Dudley;Journal of clinical oncology: official journal of the American Society of Clinical Oncology,2008

5. Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness features;Gammaitoni;Clinical cancer research: an official journal of the American Association for Cancer Research,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The safety and anti-tumor effect of multiple peptides-pulsed dendritic cells combined with induced specific cytotoxic T lymphocytes for patients with solid tumors;Frontiers in Immunology;2023-10-24

2. Significance of CD80 as a Prognostic and Immunotherapeutic Biomarker in Lung Adenocarcinoma;Biochemical Genetics;2023-03-09